Botulinum Toxin or Fillers?

Two Treatments, Two Separate Questions

Botulinum toxin and fillers are usually discussed together. But that does not mean they answer the same question.

The treatment often called Botox® in everyday speech uses botulinum toxin as its active ingredient, and that is the name used below. ‘Filler’, on the other hand, is not a single substance: it is the shared name for a family of substances that behave differently in the tissues.

Studies report that botulinum toxin type A softens lines caused by overactive muscles in both the upper and lower face. Injectable fillers, meanwhile, are used not only to reduce wrinkles but also to correct volume loss and uneven facial outlines (contour irregularities). In short, one deals with movement, the other with the tissue itself.

What Botulinum Toxin Does in the Muscle

Botulinum toxin does not cut, dissolve or move the muscle. It temporarily stops the signal between the muscle and the nerve ending that stimulates it.

How this effect comes about is understood at the molecular level. The toxin's heavy chain binds tightly to the nerve ending and allows the toxin to be taken up into the cell. Once inside the cell, the light chain acts as a zinc-dependent, protein-cutting enzyme (a metalloprotease) and cuts the SNARE proteins that the tiny sacs at the nerve ending need in order to fuse with the membrane; SNAP-25 is one of these proteins. Once these proteins are cut, the messenger chemical acetylcholine cannot be released, the muscle does not receive the command to contract, and it stays relaxed.

This is where the visible result comes from: when the muscle does not contract, the skin over it is not pulled together either, and the line caused by the contraction does not form.

Where the injection is placed also matters, because the points where nerve and muscle meet are not evenly spread through the muscle. Studies of the upper-face muscles report that in each muscle these points cluster in particular zones: in the forehead muscle, in the middle and upper parts, along the deep layer of fascia (a thin sheet of connective tissue); in the muscle that draws the brows together into a frown, mostly towards the inner part and at a deeper level; and in the muscle around the eye, spread widely along its length. However, these maps should be read as zones of probability, not as fixed boundaries. This is why a standard injection pattern does not give the same result in every face; the result depends on the person's own muscle structure.

What Filler Does in the Tissues

Filler targets the tissue, not the muscle. It takes up space in the layer where it is injected and supports the structures above it; it does not affect muscle movement.

‘Filler’ is not a single substance. Substances such as hyaluronic acid, calcium hydroxylapatite, poly-L-lactic acid and polycaprolactone differ from one another in how they work, in their flow and elasticity properties (rheology), in how long they last and in their safety.

These substances work in two different ways. Hyaluronic acid adds volume immediately and, because it can be dissolved if needed, is the first choice for many uses. Calcium hydroxylapatite, poly-L-lactic acid and polycaprolactone add volume and also stimulate the body's own collagen production; this second effect is called a biostimulatory effect. These substances, which both add volume and have a biostimulatory effect, are considered for structural support needs that call for a longer-lasting correction.

This distinction has a practical meaning: one replaces what is missing, the other tries to change the tissue's own structure. Which class of substance is used in which layer is decided at a consultation.

How to Tell Dynamic Lines from Static Lines

A simple observation tells them apart. A dynamic line appears when your face moves and disappears when your face is at rest. A static line stays in place even when your face is at rest.

What separates the two lines is not how they look but the mechanism that creates them. A dynamic line is created by muscle movement. A static line comes from changes that build up in the tissue itself; it does not disappear even when the muscle relaxes.

Even so, the two are not independent of each other. Research on botulinum toxin treatment started at an early stage shows that reducing muscle overactivity can delay the formation of dynamic wrinkles and, over time, can limit the development of static lines. However, the studies on this topic differ considerably from one another, and long-term safety and effectiveness results have not yet been fully established.

For your decision, the conclusion is this: if a line appears only with movement, the question is about the muscle. If the line is still there when your face is not moving, reducing muscle movement will not remove that line on its own.

Upper Face: The Area of Movement

Forehead lines, the vertical lines between the brows (frown lines) and the lines at the outer corners of the eyes (crow's feet) are classed as dynamic wrinkles. Research that pools the results of botulinum toxin treatment of the upper face reports a clear reduction in wrinkle severity in this area. On the other hand, these studies differ widely in their results and methods, and the findings on patient satisfaction and response rates show signs of publication bias, meaning that positive results are more likely to be published. In short, the method is reported to work in this area, but there is no single figure that applies to everyone.

On the forehead, the issue is not limited to a single muscle. The shape and position of the brow depend on the balance between the forehead muscle, which pulls the brow up, and the surrounding muscles, which pull it down. This is why research stresses that the dose, depth and injection points need to be adjusted to each person's anatomy. There is no ‘standard’ treatment for the forehead; the same amount gives two different results in two different brows.

In this area, volume is usually a secondary question, and the regulatory rules reflect this. According to information published by the US Food and Drug Administration (FDA), injecting fillers between the brows, into the nose, around the eyes, into the forehead or into the neck is not among their approved uses. This shows that lines on the upper face that become more visible with movement are addressed on the muscle-movement side, not with filler.

Mid-Face and Lower Face: The Area of Volume

The nasolabial fold (smile line) running from the side of the nose to the corner of the mouth, the cheekbone area and the chin raise a different question. Here the issue is not how much the muscle is working, but where tissue has been lost and how much.

According to information published by the FDA, absorbable fillers are approved in adults aged 22 and over for moderate to severe facial wrinkles, nasolabial folds and lines around the lips, and for adding volume to the lips, cheeks, chin and backs of the hands. The list of approved areas clearly shows which question filler answers.

The nasolabial fold is on this list, but not every fold is the same. Studies on the causes of this fold describe three types, each with a different cause and a different way of forming; differences in tissue firmness and thickness across different areas of the face also change the picture. Two folds that look the same may not have the same cause, so they may not need the same approach.

The chin and jawline are also volume-related concerns. A study that used three-dimensional volume measurement to examine hyaluronic acid (HA) filler in the chin assesses how far the chin projects and the shape of the jawline as part of the face's proportions. The muscle is not the issue here; what is measured is how a substance that takes up space supports the tissue.

When Both Come Up in the Same Face

In practice, the two questions often exist side by side in the same face. For example, lines between the brows may become more visible with movement while, at the same time, the mid-face has lost volume. In that case, asking ‘which one?’ is the wrong question; the real question is which finding should be addressed with which treatment.

Research treats this combination as a topic in its own right. The aim of combining minimally invasive methods such as fillers, thread lifts and botulinum toxin is described as achieving a balanced, natural-looking result. Three points are highlighted for this: which treatment is used in which area, how much time is left between procedures, and building a plan for the face as a whole.

What matters here is not the number of procedures but their order and the time between them. Doing everything in the same session is not a goal in itself; which finding is addressed first is decided by looking at how this will affect the result of the other.

The order matters because of the mechanisms involved. If muscle movement keeps re-creating a line, a volume correction made before that movement is reduced remains under the same strain. Conversely, when volume loss is obvious, reducing movement alone does not change how the face looks at rest. A plan like this can only be made at a consultation, with your face assessed as a whole.

When the Effect Shows and How Long It Lasts

The effect does not appear at the same time with the two treatments; this difference also comes from how each treatment works.

With hyaluronic acid fillers, the effect is visible as soon as the substance is placed; these substances are described as the group that adds volume immediately. With collagen stimulators, part of the effect depends on the body's own collagen production and develops gradually. With botulinum toxin, the effect becomes noticeable not straight after the injection but after the signal between nerve and muscle has been blocked.

It would not be accurate to give a single figure for how long the results last. These injectable corrections are considered temporary. According to information published by the FDA, some fillers are naturally absorbed over time, and how long the effect lasts depends on both the material used and the area treated. The result is also affected by the underlying tissue structure.

The durations reported in research also do not agree with one another. How long the effect may last in your case is discussed at a consultation, based on the substance used, the area and your tissues.

Their Risks and Reversibility Differ

The two treatments do not have the same side-effect profile, and it is important to know this difference when making a decision.

In an analysis that pooled data on adverse effects of non-surgical facial treatments, the reported rate of adverse effects was markedly higher with hyaluronic acid fillers than with botulinum toxin treatment of the upper face. The most commonly reported effects were swelling and pain with fillers, and headache with botulinum toxin. Data on fillers and collagen stimulators show that most reported adverse effects are mild and temporary. By contrast, vascular occlusion (a blocked blood vessel) is rare, but it must be recognised and treated quickly. These two findings do not contradict each other: more side effects are reported with fillers, most of them are mild, and the serious ones are a separate matter.

Fillers carry a rare but serious risk: if filler is accidentally injected into an artery, it can cause tissue damage, scarring, vision loss and stroke. This is why preventive techniques and recognising the problem early are crucial. This does not mean that filler should not be used; it shows that the treatment is a procedure that requires knowledge of anatomy.

Reversibility also differs. Hyaluronic acid fillers can be dissolved with an enzyme called hyaluronidase. This enzyme breaks down hyaluronic acid and is the preferred option for managing filler-related problems. However, in many countries it is used outside its licensed uses (off-label), and dosing protocols have not yet been standardised. The effect of botulinum toxin, on the other hand, cannot be dissolved; it wears off over time. In short, these two non-permanent treatments also differ in how they can be reversed.

Which Question Comes First for You

All of this comes down to one distinction. If the line you see in the mirror appears when your face moves and disappears when it is at rest, your question is one of movement. If it is still there when your face is not moving, or if you notice your contours sinking inwards and fullness decreasing, your question is one of volume.

The two can also occur together, and in most faces they do. Then the question of order comes in: which comes first, and how long after it should the other follow?

In practice, this distinction means the following: a treatment's limits show when it is the right answer to the wrong question. Adding volume to a line that appears with movement will not meet expectations, and neither will reducing movement alone in an area that has lost volume.

An article cannot tell you which one comes first for you; it can only explain how the two questions differ. You and your doctor make this distinction together at a consultation.

Treatments Offered Here

The clinic offers botulinum toxin treatments as well as hyaluronic acid and collagen-stimulating filler treatments; this also includes dissolving hyaluronic acid filler with hyaluronidase when needed. Which of these may be considered is assessed at a consultation, based on which of the two questions described above comes first for you.